[{"Assets_0_Q3_USD":1736905000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":128028000.0,"NetIncomeLoss_1_Q3_USD":44090000.0,"NetIncomeLoss_3_Q3_USD":133441000.0,"StockholdersEquity_0_Q3_USD":845800000.0,"EarningsPerShareBasic_1_Q3_USD":0.79,"EarningsPerShareBasic_3_Q3_USD":2.4,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":55548000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":55507000.0,"Ticker":"NUS","CIK":"1021561","name":"NU SKIN ENTERPRISES, INC.","OfficialName":"Nu Skin Enterprises Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2429332607.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"nan","filed":"20191106"}]